Manulife (Manufacturers Life Insurance)’s Neos Therapeutics, Inc NEOS Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-35,664	Closed	-$93K	–	2984
2019 Q1	$93K	Buy	+35,664	New	+$83.6K	﹤0.01%	2586
2018 Q3	–	Sell	-25,385	Closed	-$159K	–	4110
2018 Q2	$159K	Buy	25,385 +4,979	+24%	+$37.1K	﹤0.01%	3282
2018 Q1	$170K	Sell	20,406 -356	-2%	-$3.4K	﹤0.01%	3136
2017 Q4	$211K	Buy	20,762 +1,329	+7%	+$12.8K	﹤0.01%	2958
2017 Q3	$177K	Buy	19,433 +18,808	+3,009%	+$143K	﹤0.01%	3073
2017 Q2	$5K	Sell	625 -3,645	-85%	-$27.5K	﹤0.01%	3961
2017 Q1	$31K	Buy	4,270 +3,746	+715%	+$23.2K	﹤0.01%	3455
2016 Q4	$3K	Hold	524	–	–	﹤0.01%	4072
2016 Q3	$3K	Hold	524	–	–	﹤0.01%	4026
2016 Q2	$5K	Sell	524 -974	-65%	-$9.29K	﹤0.01%	3827
2016 Q1	$15K	Buy	+1,498	New	+$15.8K	﹤0.01%	3560

Other funds holding NEOS

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s NEOS Position: Q2 2019 in Review

Manulife (Manufacturers Life Insurance) sold out of Neos Therapeutics, Inc (NEOS) in Q2 2019, closing a stake of 35,664 shares — an estimated $93K sold.

Manulife (Manufacturers Life Insurance) first reported a position in NEOS in Q1 2016 and held it in 11 quarters. The position peaked at $211K in Q4 2017. 58 funds tracked by Wall St. Rank hold NEOS as of Q2 2019.

Manulife (Manufacturers Life Insurance) reported no remaining Neos Therapeutics, Inc position as of Q2 2019 after selling out during the quarter.
Manulife (Manufacturers Life Insurance) sold 35,664 Neos Therapeutics, Inc shares in Q2 2019, an estimated $93K.
Manulife (Manufacturers Life Insurance) first reported a position in Neos Therapeutics, Inc in Q1 2016 and held it in 11 quarters.
Manulife (Manufacturers Life Insurance)'s Neos Therapeutics, Inc position peaked at $211K in Q4 2017.
58 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2019.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2019, filed 14 Aug 2019.